Details of the Drug

General Information of Drug (ID: DMENHCI)

• Drug Name: Kawain
• Synonyms: kavain; 3155-48-4; DL-KAWAIN; Neuronica; Cavain; DL-Kavain; 1635-33-2; MLS000069449; SMR000059008; 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-(2-phenylethenyl)-; Gonosan; 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-styryl-; kavaine; trans-5,6-Dihydro-4-methoxy-6-(2-phenylethenyl)-2H-pyran-2-one; C14H14O3; rac-Kavain; 2,6-Heptadienoic acid, 5-hydroxy-3-methoxy-7-phenyl-, delta-lactone; D,L-Kawin; Kawain, DL-; Kawain (+-)-form; DL-Kavain, primary pharmaceutical reference standard; kavain, (R)-(E)-isomer; EINECS 207-907-2; CCRIS 9373

Indication

Disease Entry	ICD 11	Status	REF
Cardiovascular disease	BA00-BE2Z	Approved	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C14H14O3
  Canonical SMILES: COC1=CC(=O)OC(C1)C=CC2=CC=CC=C2
  InChI: InChI=1S/C14H14O3/c1-16-13-9-12(17-14(15)10-13)8-7-11-5-3-2-4-6-11/h2-8,10,12H,9H2,1H3/b8-7+/t12-/m0/s1
  InChIKey: XEAQIWGXBXCYFX-GUOLPTJISA-N
• Cross-matching ID:
  PubChem CID: 5281565
  ChEBI ID: CHEMBL6117
  CAS Number: 500-64-1
  TTD ID: D0L1WV
• Drug Pharmacogenomic Perturbation (DPP)NEW: Click to Jump to the Detailed DPP Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015